Location History:
- St. Louis, MO (US) (2001)
- St. Louis, MI (US) (2001)
Company Filing History:
1 out of 1 
1 out of 832,812 Years Active: 2001
Title: The Innovative Contributions of David Schlessinger
Introduction
David Schlessinger, an accomplished inventor based in St. Louis, MO, has made significant strides in the field of genetics and molecular biology. With two patents to his name, his work primarily focuses on advancements related to fragile X syndrome, a genetic condition characterized by intellectual disabilities.
Latest Patents
Schlessinger's latest patents revolve around monoclonal and polyclonal antibodies that directly relate to fragile X syndrome. He has successfully obtained the DNA sequence spanning the fragile X site on the X human chromosome in a purified and isolated form. This breakthrough is crucial as fragile X is associated with mental retardation, and the availability of such DNA allows for enhanced diagnosis and treatment of associated mental disorders. Furthermore, his patents disclose polyclonal and monoclonal antibodies targeting an amino acid sequence encoded by a specific DNA sequence from the fragile X site, providing essential tools for further research and therapeutic applications.
Career Highlights
Throughout his career, Schlessinger has been associated with the Adelaide Medical Centre for Women and Children, where he contributed to various projects, advancing the understanding of genetic disorders. His work exemplifies the intersection of rigorous scientific research and practical medical applications, showcasing his dedication to improving patient outcomes.
Collaborations
In his endeavors, Schlessinger has collaborated with notable colleagues such as Grant R. Sutherland and Robert I. Richards. These collaborations have enriched his research and have further propelled advancements in the understanding of fragile X syndrome.
Conclusion
David Schlessinger's contributions to science through his patents and collaborations demonstrate the impact of innovative thinking in addressing complex genetic conditions. His work serves as an inspiration for future inventors and researchers in the field of genetics and beyond.